Toward quantification of loop diuretic responsiveness for congestive heart failure

被引:2
作者
Oyama, Mark A. [1 ,3 ]
Adin, Darcy [2 ]
机构
[1] Univ Penn, Clin Sci & Adv Med, MJR VHUP Cardiol, Philadelphia, PA USA
[2] Univ Florida, Large Anim Clin Sci, Gainesville, FL USA
[3] Univ Penn, Clin Sci & Adv Med, MJR VHUP Cardiol, 3900 Delancey St, Philadelphia, PA 19147 USA
关键词
diuretic resistance; furosemide; natriuresis; parenchymal disease; pulmonary edema; respiratory tract; SPOT URINE SODIUM; FUROSEMIDE; RESISTANCE; FLUID; HYPONATREMIA; HYPOCHLOREMIA; DEHYDRATION; NATRIURESIS; ASSOCIATION; EXCRETION;
D O I
10.1111/jvim.16590
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Diuretics, such as furosemide, are routinely administered to dogs with congestive heart failure (CHF). Traditionally, dose and determination of efficacy primarily are based on clinical signs rather than quantitative measures of drug action. Treatment of human CHF patients increasingly is guided by quantification of urine sodium concentration (uNa) and urine volume after diuretic administration. Use of these and other measures of diuretic responsiveness is associated with decreased duration of hospitalization, complication rates, future rehospitalization, and mortality. At their core, loop diuretics act through natriuresis, and attention to body sodium (Na) stores and handling offers insight into the pathophysiology of CHF and pharmacology of diuretics beyond what is achievable from clinical signs alone. Human patients with low diuretic responsiveness or diuretic resistance are at risk for difficult or incomplete decongestion that requires diuretic intensification or other remedial strategies. Identification of the specific etiology of resistance in a patient can help tailor personalized interventions. In this review, we advance the concept of loop diuretic responsiveness by highlighting Na and natriuresis. Specifically, we review body water homeostasis and congestion in light of the increasingly recognized role of interstitial Na, propose definitions for diuretic responsiveness and resistance in veterinary subjects, review relevant findings of recent studies, explain how the particular cause of resistance can guide treatment, and identify current knowledge gaps. We believe that a quantitative approach to loop diuretic usage primarily involving natriuresis will advance our understanding and care of dogs with CHF.
引用
收藏
页码:12 / 21
页数:10
相关论文
共 50 条
  • [31] Loop diuretic resistance complicating acute heart failure
    Cox, Zachary L.
    Testani, Jeffrey M.
    [J]. HEART FAILURE REVIEWS, 2020, 25 (01) : 133 - 145
  • [32] Diuretic Responsiveness and Its Prognostic Significance in Children With Heart Failure
    Price, Jack F.
    Younan, Samuel
    Cabrera, Antonio G.
    Denfield, Susan W.
    Tunuguntla, Hari
    Choudhry, Swati
    Dreyer, William J.
    Akcan-Arikan, Ayse
    [J]. JOURNAL OF CARDIAC FAILURE, 2019, 25 (12) : 941 - 947
  • [33] Optimal diuretic strategies in heart failure
    Suri, Sarabjeet S.
    Pamboukian, Salpy V.
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (06)
  • [34] Diuretic Resistance Associated With Heart Failure
    Shams, Elham
    Bonnice, Sabrina
    Mayrovitz, Harvey N.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (01)
  • [35] Hypertonic saline with furosemide for diuretic resistant congestive heart failure in an infant
    Shiraishi, Masahiro
    Murakami, Tomoaki
    Nawa, Tomohiro
    Kobayashi, Hironobu
    Nagamine, Hiroki
    Shiraga, Kazuhiro
    Higashi, Kouji
    Nakajima, Hiromichi
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 215 : 127 - 128
  • [36] Diuretic response and effects of diuretic omission in ambulatory heart failure patients on chronic low-dose loop diuretic therapy
    Dauw, Jeroen
    Martens, Pieter
    Tersalvi, Gregorio
    Schouteden, Joren
    Deferm, Sebastien
    Gruwez, Henri
    De Moor, Bart
    Nijst, Petra
    Dupont, Matthias
    Mullens, Wilfried
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (07) : 1110 - 1119
  • [37] Torsemide Is a More Appropriate Oral Loop Diuretic for Patients with Heart Failure: PRO
    Macon, Conrad J.
    Ellison, David H.
    [J]. KIDNEY360, 2024, 5 (08): : 1072 - 1074
  • [38] The Potential Role of Torsemide in Optimizing Loop Diuretic Therapy for Heart Failure Patients
    Chopra, V. K.
    Mohanan, P. P.
    Kher, Vijay
    Mantri, Raja Ram
    Isaacs, Rajan
    Jadhav, Uday
    Zalte, Nitin
    Sugumaran, Amarnath
    Mohanasundaram, Senthilnathan
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [39] Ways of Optimizing Diuretic Therapy in Chronic Congestive Heart Failure, - Place of Torasemide Prolonged Release
    Kobalava, Zh. D.
    Kiyakbaev, G. K.
    [J]. KARDIOLOGIYA, 2014, 54 (04) : 69 - +
  • [40] Diuretic strategies in acute decompensated heart failure
    Lo, Kevin Bryan
    Nohria, Anju
    [J]. HEART FAILURE REVIEWS, 2025, 30 (02) : 417 - 430